Zhejiang Huahai Pharmaceutical Co., Ltd. Class A · SSE:600521

Zhejiang Huahai Pharmaceutical Co., Ltd. Class A financial statements

Zhejiang Huahai Pharmaceutical Co., Ltd. Class A's income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.

Financials

Annual, in CNY

Income statement

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue8.59B9.55B8.31B8.27B6.64B6.49B5.39B5.09B5.00B4.09B
Cost of revenue3.42B3.74B3.38B3.18B2.67B2.38B2.20B2.14B2.20B2.05B
Gross profit5.17B5.81B4.93B5.09B3.97B4.10B3.19B2.95B2.80B2.04B
Research and development1.23B986.7M983.0M925.5M942.3M565.7M467.4M396.8M353.4M364.0M
Selling, general and administrative2.11B1.46B1.30B1.29B1.27B1.08B895.6M839.8M646.6M852.9M
Operating income833.5M1.47B1.12B1.55B868.4M1.29B824.4M475.2M791.2M508.0M
Depreciation and amortization1.01B916.8M789.6M672.0M563.1M470.8M410.7M345.0M289.9M251.0M
EBITDA1.84B2.39B1.91B2.22B1.43B1.76B1.24B820.3M1.08B759.0M
Interest expense233.6M226.1M237.8M223.9M170.7M139.1M234.9M150.4M65.2M45.4M
Income before tax443.9M1.46B1.10B1.51B786.9M1.22B760.9M157.2M779.2M567.1M
Income tax356.1M283.1M332.9M306.3M220.8M154.0M22.3M155.7M110.2M
Net income266.4M1.12B830.5M1.17B487.5M929.8M569.6M107.5M639.2M500.8M
Earnings per share, basic0.180.770.570.800.340.640.390.080.460.37

Balance sheet

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash and equivalents1.50B1.54B1.34B1.37B1.88B2.21B1.50B910.8M691.3M791.6M
Short-term investments76.0M60.8M93.0M143.1M1.01M2.05K
Receivables2.87B3.27B2.68B2.83B1.91B1.76B1.40B1.94B1.66B1.35B
Inventory3.71B3.41B3.43B3.37B2.74B2.37B2.22B2.18B1.59B1.33B
Current assets8.74B8.48B7.62B7.91B6.81B6.52B5.27B5.21B4.07B3.51B
Property, plant and equipment5.96B4.37B3.80B3.52B2.94B2.56B
Goodwill64.4M64.4M64.4M70.9M70.9M70.9M70.9M70.9M70.9M70.9M
Total assets21.5B20.3B18.6B18.2B15.5B13.0B10.7B10.4B8.27B6.73B
Accounts payable1.81B1.59B1.39B1.20B881.8M392.5M577.0M662.6M759.4M175.3M
Current liabilities9.11B5.98B5.45B4.80B4.24B2.89B3.36B4.77B2.84B1.51B
Long-term debt1.84B4.39B4.02B4.64B3.50B2.92B1.18B900.0M222.2M534.7M
Total debt6.52B5.65B6.86B5.63B4.05B3.31B3.55B1.81B1.02B
Total liabilities12.0B11.2B10.3B10.4B8.69B6.27B4.95B6.16B3.21B2.15B
Shareholders' equity9.44B8.90B8.08B7.55B6.56B6.51B5.61B4.07B4.88B4.38B
Shares outstanding1.50B1.45B1.46B1.46B1.45B1.45B1.45B1.31B1.38B1.35B

Cash flow

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operations1.23B2.17B2.22B1.24B938.4M1.56B1.75B67.9M546.2M433.1M
Capital spending-1.97B-1.85B-1.59B-2.32B-2.43B-1.28B-794.3M-1.12B-794.5M-732.9M
Free cash flow-736.0M319.3M624.6M-1.07B-1.50B279.0M959.6M-1.06B-248.3M-299.8M
Cash from investing-1.92B-1.62B-2.43B-2.36B-1.36B-791.1M-1.26B-1.14B-706.7M
Cash from financing-132.9M-644.2M609.0M1.12B596.3M-400.3M1.35B556.6M408.8M
Dividends paid-546.2M-475.4M-556.0M-147.3M-290.9M-392.8M-208.9M-308.0M-241.6M-194.4M
Share buybacks-189.9M-71.0M-172.4M-150.0M-4.75M
Change in cash-31.0M170.6M-21.0M-526.2M-343.6M708.9M591.3M219.6M-74.1M185.9M